Wednesday, October 5, 2016

Vicks Sinex Decongestant Nasal Spray





1. Name Of The Medicinal Product



Vicks Sinex Decongestant Nasal Spray


2. Qualitative And Quantitative Composition



ACTIVE INGREDIENT










 



 




Percentage quantity




Specification




Oxymetazoline hydrochloride




0.050% w/v




Ph. Eur



3. Pharmaceutical Form



Non-pressurised, aqueous nasal spray solution.



4. Clinical Particulars



4.1 Therapeutic Indications



The symptomatic relief of congestion of the upper respiratory tract due to the common cold, hay fever and sinusitis.



4.2 Posology And Method Of Administration






Adults and children over 12 years:




1-2 sprays per nostril every 6-8 hours unless otherwise advised by your doctor.



Topical application as a nasal spray.



4.3 Contraindications



See your doctor for advice before taking this medicine if you suffer from high blood pressure, any heart complaint, diabetes, thyroid disease, hepatic or renal disorders.



4.4 Special Warnings And Precautions For Use



See your doctor if you feel worse or do not feel better after 7 days. Inform your doctor if you develop new symptoms.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



If you are taking other medicines, you should see your doctor for advice before taking this medicine.



4.6 Pregnancy And Lactation



Before using this medicine, obtain advice from your doctor if you intend to become pregnant, are pregnant or are breast-feeding.



4.7 Effects On Ability To Drive And Use Machines



None known.



4.8 Undesirable Effects



None known.



4.9 Overdose



4.9.1 Symptoms



No information.



4.9.2 Treatment of overdose



No information.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties






Oxymetazoline hydrochloride:




α-Adrenergic imidazoline derivative, providing localised nasal vasoconstriction.



5.2 Pharmacokinetic Properties



Not applicable. The product provides purely local action.



5.3 Preclinical Safety Data



Not applicable.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Menthol



Eucalyptol



Sodium citrate dihydrate



Tyloxapol



Citric acid anhydrous



Chlorhexidine digluconate



Benzalkonium chloride



Camphor



Disodium edetate



Sodium hydroxide



Purified water



6.2 Incompatibilities



None known.



6.3 Shelf Life



3 years.



6.4 Special Precautions For Storage



None.



6.5 Nature And Contents Of Container



15ml or 20ml polyethylene/polypropylene copolymer bottle with L. D polyethylene dip tube to spray orifice. Green polypropylene screw cap.



6.6 Special Precautions For Disposal And Other Handling



Not applicable.



7. Marketing Authorisation Holder



Procter & Gamble (Health & Beauty Care) Limited



The Heights,



Brooklands,



Weybridge,



Surrey



KT13 0XP



8. Marketing Authorisation Number(S)



PL 0129/5011R



9. Date Of First Authorisation/Renewal Of The Authorisation



12th June 1990



10. Date Of Revision Of The Text



June 2009





No comments:

Post a Comment